Cancer AI Alliance Launches with $40 Million Backing to Advance Precision Medicine
A coalition of cancer care institutions has launched the Cancer AI Alliance initiative, focused on the AI integration to transform cancer treatment, following a successful $40 million funding round from tech leaders to use to advance precision medicine in cancer care.
AI Integration in Cancer Treatment
The AI integration partnership includes some of the most well-known organizations, with the most prominent one being Fred Hutchinson Cancer Research Center that will lead the effort, along with Johns Hopkins, Dana-Farber Cancer Institute, and Memorial Sloan Kettering Cancer Center.
Tom Lynch, President and Director of Fred Hutch, announced the initiative during the Intelligent Applications Summit in Seattle, with Lynch highlighting that this collaboratory effort “represents an unprecedented ability… to agree that working together will enable progress.”
One of the critical challenges that the alliance tries to solve is the isolation of knowledge in cancer treatment. For example, if one facility can treat a rare pediatric cancer, a patient in another institution might not have a chance to get the novel protocol treatment. Scientific literature, Lynch emphasized, often takes so long to distribute that it cannot help maintaining timely care for those patients with aggressive types of cancers.
AI has the potential to increase the speed with which information and treatment possibilities are shared between institutions. Data sharing between medical organizations is problematic due to regulations around safety and differences in the formatting of data, even when studies on the same topic exist across different institutions, both legal and technical issues inhibit their combined use in many instances.
This will be overcome by the CAIA with federated learning, a secure method of data collaboration that will allow organizations to train AI models on raw data without compromising data privacy. In so doing, member organizations can work together toward a common AI integration goal, such as developing models of drug discovery or diagnostics for particular cancers, while remaining HIPAA-compliant and adhering to other regulations.
This vision, to create such a collaborative system, is ambitious, said Jeff Leek, Vice President and Chief Data Officer at Fred Hutch, but doable with the right participants and resources. To make that AI integration foundational framework, it required building partnerships with top comprehensive cancer research centers and tech giants like Microsoft, AWS, Nvidia, and Deloitte.
The $40 million financing for the Center AI in Alliance (CAIA) will cover operational expenses, service, and other supplies, with the expectation of becoming fully functional by the end of 2024. The first outcomes from this initiative are anticipated to end by 2025, with an exclusive focus on collaborative research for cancer treatments through AI integration solutions.
Inside Telecom provides you with an extensive list of content covering all aspects of the Tech industry. Keep an eye on our Medtech section to stay informed and updated with our daily articles.